Please join us in congratulating nine new Clinical and Translational Science Institute scholars, recipients of career development awards designed to support junior investigators as they build independent research careers.
The New Investigator Pre-K Pilot Grant provides mentorship, oversight, and pilot funds to junior investigators interested in clinical and translational research. The program is designed to prepare investigators to successfully compete for NIH K or R awards.
Naomi Duke, Division of Adolescent Health and Medicine, Pediatrics, Medical School
Identifying Mechanisms for Health Disparities: Exploring the Impact of Youth Survival Expectations on Future Health
Stephanie Misono, Department of Otolaryngology, Medical School
Development of online intervention for distressed voice-disordered patients
Rebecca Shlafer, Division of Adolescent Health and Medicine, Pediatrics, Medical School
Nutritional Status and Unmet Needs among Incarcerated Women of Reproductive Age
The K to R Transition Grant aims to place junior investigators, who have K awards, further on the path to be competitive for R01 awards.
Cari Clark, Department of General Medicine, Medical School
Impact of Yoga on Violence Survivor's Mental and Cardio Metabolic Health: A Feasibility Study of a Cluster Randomized Trial
Terri Laguna, Divsion of Pediatric Pulmonary Medicine, Pediatrics, Medical School
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
The R to R Pilot Grant provides research funds for first time R01 awardees in clinical and translational research or funded junior faculty in the basic sciences who need pilot data to transition to translational work. This program provides supplemental funds to ensure that awardees compete successfully for a second NIH R01.
Alvaro Alonso, Division of Epidemiology and Community Health, School of Public Health
Comparative Effectiveness of New Oral Anticoagulants in Atrial Fibrillation
Robert Jones, Division of Pediatrics, Developmental/Surgical Sciences, School of Dentistry
Examining Combination Antimicrobial Therapies to Control Pathogenic Oral Biofilms in Young Children
Erik Peterson, Division of Rheumatic & Autoimmune, Medicine, Medical School
PTPN22: genetic determinant of vaccine efficacy
Marnie Peterson, Division of Experimental and Clinical Pharmacology, College of Pharmacy
Alpha toxin: Role in biofilm formation by MRSA wound isolates and therapeutic target